Dermata Therapeutics, Inc. (DRMA) vs Gelteq Limited Ordinary Shares (GELS)

A side-by-side comparison of Dermata Therapeutics, Inc. and Gelteq Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Dermata Therapeutics, Inc. logo
DRMA
Dermata Therapeutics, Inc.
$4M
$1.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Gelteq Limited Ordinary Shares logo
GELS
Gelteq Limited Ordinary Shares
$5M
$0.54HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — DRMA vs GELS

growth of $100 · dividends reinvested · last 2y
DRMA -92.4% (-72.4%/yr)GELS -81.5% (-57.0%/yr)GELS compounded faster over this window
050100150Start $10020252026$8$18
DRMA GELS

DRMA vs GELS: by the numbers

  • •GELS is the larger company ($5M vs $4M market cap).
  • •Both run net losses; DRMA's is the smaller (0.00% vs -4011.86% net margin).

Metrics side by side

Valuation

MetricDRMAGELS
P/B ratio1.280.53

Profitability

MetricDRMAGELS
Gross margin0.00%100.00%
Operating margin0.00%-3317.65%
Net margin0.00%-4011.86%
ROE-239.95%-42.05%
ROIC-246.61%-27.41%

Growth (annualized)

MetricDRMAGELS
Total return CAGR (5Y)-83.90%N/A

Go deeper

Full DRMA analysisFull GELS analysisInteractive comparison tool

Dig into the metrics

Dermata Therapeutics ROEGelteq Limited Ordinary Shares ROEDermata Therapeutics operating marginGelteq Limited Ordinary Shares operating marginDermata Therapeutics revenue growthGelteq Limited Ordinary Shares revenue growthDermata Therapeutics free cash flowGelteq Limited Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.